Amoxycillin/clavulanate resistant Escherichia coli
- PMID: 2893121
- DOI: 10.1016/s0140-6736(88)90391-1
Amoxycillin/clavulanate resistant Escherichia coli
Similar articles
-
Activity of amoxycillin/clavulanate against beta-lactamase-producing Escherichia coli and Klebsiella spp.J Antimicrob Chemother. 1989 Nov;24 Suppl B:41-7. doi: 10.1093/jac/24.suppl_b.41. J Antimicrob Chemother. 1989. PMID: 2691485
-
In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.Arzneimittelforschung. 1988 Jul;38(7):863-5. Arzneimittelforschung. 1988. PMID: 3061383
-
Amoxycillin/clavulanate resistant Escherichia coli.Lancet. 1988 Mar 26;1(8587):704. doi: 10.1016/s0140-6736(88)91500-0. Lancet. 1988. PMID: 2895231 No abstract available.
-
A review of the microbiology of amoxycillin/clavulanic acid over the 15 year period 1978-1993.J Chemother. 1994 Oct;6(5):283-318. doi: 10.1080/1120009x.1994.11741165. J Chemother. 1994. PMID: 7861195 Review.
-
Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.Clin Pharm. 1984 Nov-Dec;3(6):591-9. Clin Pharm. 1984. PMID: 6391783 Review.
Cited by
-
Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.Antimicrob Agents Chemother. 1991 Mar;35(3):524-8. doi: 10.1128/AAC.35.3.524. Antimicrob Agents Chemother. 1991. PMID: 2039203 Free PMC article.
-
Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.Antimicrob Agents Chemother. 1994 Mar;38(3):494-8. doi: 10.1128/AAC.38.3.494. Antimicrob Agents Chemother. 1994. PMID: 8203843 Free PMC article.
-
Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1990 Feb;39(2):264-307. doi: 10.2165/00003495-199039020-00008. Drugs. 1990. PMID: 2184003 Review.
-
Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.PLoS One. 2013;8(2):e56926. doi: 10.1371/journal.pone.0056926. Epub 2013 Feb 21. PLoS One. 2013. PMID: 23437273 Free PMC article.
-
Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model.Antimicrob Agents Chemother. 1993 Mar;37(3):610-2. doi: 10.1128/AAC.37.3.610. Antimicrob Agents Chemother. 1993. PMID: 8460928 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources